Skip to main content
. 2020 Dec 31;21(2):159. doi: 10.3892/ol.2020.12420

Figure 3.

Figure 3.

Overall survival of 161 patients with pancreatic adenocarcinoma in relation to B3GNT3 status. Patients with pancreatic cancer with higher B3GNT3 expression had poorer outcomes. The P-value shown in the figure applies to the comparison of all groups. B3GNT3, βGal β-1,3-N-acetylglucosaminyltransferase 3.